Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
- Author
- MILOJKOVIC, Dragana1 ; NICHOLSON, Emma2 ; KHORASHAD, Jamshid S1 ; DE LAVALLADE, Hugues1 ; REZVANI, Katy1 ; PALIOMPEIS, Christos1 ; GOLDMAN, John M1 ; MARIN, David1 ; APPERLEY, Jane F1 ; HOLYOAKE, Tessa L2 ; SHEPHERD, Pat3 ; DRUMMOND, Mark W2 ; SZYDIO, Richard1 ; BUA, Marco1 ; FORONI, Letizia1 ; REID, Alistair1
[1] Department of Haematology, Hammersmith Hospitals Trust, Imperial College London, London, United Kingdom
[2] Department of Haematology, The Beatson West of Scotland Cancer Centre and Section of Experimental Haematology, Faculty of Medicine, University of Glasgow, Glasgow, United Kingdom
[3] Department of Haematology, Western General Hospital, Edinburgh, United Kingdom - Source
Haematologica (Roma). 2010, Vol 95, Num 2, pp 224-231, 8 p ; ref : 30 ref
- ISSN
- 0390-6078
- Scientific domain
- Hematology
- Publisher
- Ferrata Storti Foundation, Pavia
- Publication country
- Italy
- Document type
- Article
- Language
- English
- Author keyword
- chronic myeloid leukemia early prediction tyrosine kinase inhibitors
- Keyword (fr)
- Facteur prédictif Homme Hématologie Inhibiteur de la tyrosine kinase Leucémie myéloïde chronique Précoce Traitement Cancer Hémopathie maligne Syndrome myéloprolifératif
- Keyword (en)
- Predictive factor Human Hematology Tyrosine kinase inhibitor Chronic myelogenous leukemia Early Treatment Cancer Malignant hemopathy Myeloproliferative syndrome
- Keyword (es)
- Factor predictivo Hombre Hematología Inhibidor tyrosine kinase Leucemia mieloidea crónica Precoz Tratamiento Cáncer Hemopatía maligna Mieloproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22477966
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.3324/haematol.2009.012781 
https://dx.doi.org/10.3324/haematol.2009.012781
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.3324\/haematol.2009.012781\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"224\";s:8:\"\u0000*\u0000epage\";s:3:\"231\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MILOJKOVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Dragana\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"NICHOLSON, Emma\";i:1;s:20:\"KHORASHAD, Jamshid S\";i:2;s:20:\"DE LAVALLADE, Hugues\";i:3;s:13:\"REZVANI, Katy\";i:4;s:20:\"PALIOMPEIS, Christos\";i:5;s:15:\"GOLDMAN, John M\";i:6;s:12:\"MARIN, David\";i:7;s:16:\"APPERLEY, Jane F\";i:8;s:17:\"HOLYOAKE, Tessa L\";i:9;s:13:\"SHEPHERD, Pat\";i:10;s:16:\"DRUMMOND, Mark W\";i:11;s:15:\"SZYDIO, Richard\";i:12;s:10:\"BUA, Marco\";i:13;s:15:\"FORONI, Letizia\";i:14;s:14:\"REID, Alistair\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:25:\"Ferrata Storti Foundation\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.3324\/haematol.2009.012781\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"224\";s:8:\"\u0000*\u0000epage\";s:3:\"231\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MILOJKOVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Dragana\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"NICHOLSON, Emma\";i:1;s:20:\"KHORASHAD, Jamshid S\";i:2;s:20:\"DE LAVALLADE, Hugues\";i:3;s:13:\"REZVANI, Katy\";i:4;s:20:\"PALIOMPEIS, Christos\";i:5;s:15:\"GOLDMAN, John M\";i:6;s:12:\"MARIN, David\";i:7;s:16:\"APPERLEY, Jane F\";i:8;s:17:\"HOLYOAKE, Tessa L\";i:9;s:13:\"SHEPHERD, Pat\";i:10;s:16:\"DRUMMOND, Mark W\";i:11;s:15:\"SZYDIO, Richard\";i:12;s:10:\"BUA, Marco\";i:13;s:15:\"FORONI, Letizia\";i:14;s:14:\"REID, Alistair\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:25:\"Ferrata Storti Foundation\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.3324\/haematol.2009.012781\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.3324\/haematol.2009.012781\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"224\";s:8:\"\u0000*\u0000epage\";s:3:\"231\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MILOJKOVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Dragana\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"NICHOLSON, Emma\";i:1;s:20:\"KHORASHAD, Jamshid S\";i:2;s:20:\"DE LAVALLADE, Hugues\";i:3;s:13:\"REZVANI, Katy\";i:4;s:20:\"PALIOMPEIS, Christos\";i:5;s:15:\"GOLDMAN, John M\";i:6;s:12:\"MARIN, David\";i:7;s:16:\"APPERLEY, Jane F\";i:8;s:17:\"HOLYOAKE, Tessa L\";i:9;s:13:\"SHEPHERD, Pat\";i:10;s:16:\"DRUMMOND, Mark W\";i:11;s:15:\"SZYDIO, Richard\";i:12;s:10:\"BUA, Marco\";i:13;s:15:\"FORONI, Letizia\";i:14;s:14:\"REID, Alistair\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:25:\"Ferrata Storti Foundation\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.3324\/haematol.2009.012781\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"224\";s:8:\"\u0000*\u0000epage\";s:3:\"231\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MILOJKOVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Dragana\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"NICHOLSON, Emma\";i:1;s:20:\"KHORASHAD, Jamshid S\";i:2;s:20:\"DE LAVALLADE, Hugues\";i:3;s:13:\"REZVANI, Katy\";i:4;s:20:\"PALIOMPEIS, Christos\";i:5;s:15:\"GOLDMAN, John M\";i:6;s:12:\"MARIN, David\";i:7;s:16:\"APPERLEY, Jane F\";i:8;s:17:\"HOLYOAKE, Tessa L\";i:9;s:13:\"SHEPHERD, Pat\";i:10;s:16:\"DRUMMOND, Mark W\";i:11;s:15:\"SZYDIO, Richard\";i:12;s:10:\"BUA, Marco\";i:13;s:15:\"FORONI, Letizia\";i:14;s:14:\"REID, Alistair\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:25:\"Ferrata Storti Foundation\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.3324\/haematol.2009.012781\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"95\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"224\";s:8:\"\u0000*\u0000epage\";s:3:\"231\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MILOJKOVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Dragana\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"NICHOLSON, Emma\";i:1;s:20:\"KHORASHAD, Jamshid S\";i:2;s:20:\"DE LAVALLADE, Hugues\";i:3;s:13:\"REZVANI, Katy\";i:4;s:20:\"PALIOMPEIS, Christos\";i:5;s:15:\"GOLDMAN, John M\";i:6;s:12:\"MARIN, David\";i:7;s:16:\"APPERLEY, Jane F\";i:8;s:17:\"HOLYOAKE, Tessa L\";i:9;s:13:\"SHEPHERD, Pat\";i:10;s:16:\"DRUMMOND, Mark W\";i:11;s:15:\"SZYDIO, Richard\";i:12;s:10:\"BUA, Marco\";i:13;s:15:\"FORONI, Letizia\";i:14;s:14:\"REID, Alistair\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:25:\"Ferrata Storti Foundation\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
